Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab

MeSH terms

• Antibodies, Monoclonal, Humanized / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bevacizumab
• Brain Neoplasms / diagnosis*
• Brain Neoplasms / drug therapy
• Cell Transformation, Neoplastic / drug effects*
• Child, Preschool
• Dacarbazine / administration & dosage
• Dacarbazine / analogs & derivatives
• Dihydroxyphenylalanine / analogs & derivatives*
• Disease Progression
• Female
• Fluorine Radioisotopes
• Ganglioglioma / diagnosis*
• Ganglioglioma / drug therapy
• Humans
• Magnetic Resonance Imaging*
• Positron-Emission Tomography*
• Prognosis
• Radiopharmaceuticals
• Temozolomide